Taken together, these results suggest Reelin as a promoter and biomarker of endothelial dysfunction and potentially of inflammation, which is activated during inflammatory diseases such as atherosclerosis, multiple sclerosis, and now COVID-19. This evidence concerns the gene RELN and multiple sclerosis.